
CB Therapeutics
CB Therapeutics is a YC Summer 2018 (S18) company. Based in San Diego, CA, USA. Team of 18.
About CB Therapeutics
Summary
CB Therapeutics engineers yeast-based fermentation to produce cannabinoids, tryptamines, and other rare alkaloids at scale, replacing crop extraction and chemical synthesis as the supply route for these compounds. Its AI-guided biosynthetic platform spans eight compound classes, including phytocannabinoids, ergolines, and peptides, running each molecule through repeated design-build-test cycles to hit target purity and consistency. The company targets both therapeutic development, addressing conditions such as depression, PTSD, and opioid addiction, and commercial ingredient supply for wellness markets.
From the Y Combinator listing
Fermentation-derived natural products to solve health problems
CB Therapeutics is a synthetic biology company focused on bringing cannabinoid and tryptamine therapeutics to the clinic and commercial markets to treat depression, PTSD, opioid addiction, alcoholism, pain, and other mental health problems.
Facts
- Healthcare / Healthcare -> Industrial Bio
- San Diego, CA, USA
- 18
- Active
- Early
Founders (2)
- Jacob Vogan
- Sher Butt
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works